Free Trial

Supernus Pharmaceuticals (SUPN) SEC Filings & 10K Form

Supernus Pharmaceuticals logo
$36.28 -0.12 (-0.33%)
(As of 03:16 PM ET)

Recent Supernus Pharmaceuticals SEC Filings

DateFilerForm TypeView
11/04/2024
3:19 PM
Supernus Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
11/01/2024
3:35 PM
MACQUARIE GROUP LTD (Filed by)
Supernus Pharmaceuticals (Subject)
Form SC 13G/A
10/31/2024
10:55 AM
DIMENSIONAL FUND ADVISORS LP (Filed by)
Supernus Pharmaceuticals (Subject)
Form SC 13G
10/21/2024
3:48 PM
Supernus Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/17/2024
3:16 PM
Supernus Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/10/2024
4:03 PM
Supernus Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/13/2024
3:30 PM
GEMAYEL GEORGES (Reporting)
Supernus Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/20/2024
4:00 PM
Bhatt Padmanabh P. (Reporting)
Supernus Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/19/2024
6:03 AM
Supernus Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/06/2024
3:16 PM
Supernus Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/06/2024
3:18 PM
Supernus Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/01/2024
3:19 PM
Martin Tami Tillotson (Reporting)
Supernus Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
07/31/2024
3:41 PM
Martin Tami Tillotson (Reporting)
Supernus Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
07/24/2024
3:48 PM
Martin Tami Tillotson (Reporting)
Supernus Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
07/23/2024
3:20 PM
Supernus Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/22/2024
3:24 PM
Martin Tami Tillotson (Reporting)
Supernus Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
07/19/2024
3:28 PM
Martin Tami Tillotson (Reporting)
Supernus Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
07/16/2024
3:14 PM
Martin Tami Tillotson (Reporting)
Supernus Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
07/16/2024
3:18 PM
Martin Tami Tillotson (Reporting)
Supernus Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
07/15/2024
3:53 PM
Martin Tami Tillotson (Reporting)
Supernus Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
06/17/2024
4:15 PM
Supernus Pharmaceuticals (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
05/09/2024
3:09 PM
Supernus Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/24/2024
3:05 PM
Supernus Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/24/2024
3:08 PM
Supernus Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/08/2024
7:03 AM
Supernus Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/25/2024
4:00 PM
Bhatt Padmanabh P. (Reporting)
Supernus Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/22/2024
4:00 PM
Bhatt Padmanabh P. (Reporting)
Supernus Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/21/2024
4:01 PM
Bhatt Padmanabh P. (Reporting)
Supernus Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/15/2024
5:39 PM
Bhatt Padmanabh P. (Reporting)
Supernus Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/14/2024
4:00 PM
Bhatt Padmanabh P. (Reporting)
Supernus Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/13/2024
3:23 PM
Bhatt Padmanabh P. (Reporting)
Supernus Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/29/2024
4:00 PM
Khattar Jack A. (Reporting)
Supernus Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/29/2024
4:01 PM
Mottola Frank (Reporting)
Supernus Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/22/2024
4:28 PM
Khattar Jack A. (Reporting)
Supernus Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/14/2024
1:33 PM
ARMISTICE CAPITAL, LLC (Filed by)
Supernus Pharmaceuticals (Subject)
Form SC 13G/A
02/14/2024
6:06 AM
MACQUARIE GROUP LTD (Filed by)
Supernus Pharmaceuticals (Subject)
Form SC 13G
02/05/2024
8:21 AM
Supernus Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/19/2024
1:40 PM
BlackRock Inc. (Filed by)
Supernus Pharmaceuticals (Subject)
Form SC 13G/A
01/10/2024
3:08 PM
Martin Tami Tillotson (Reporting)
Supernus Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
12/26/2023
4:00 PM
Khattar Jack A. (Reporting)
Supernus Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/26/2023
4:01 PM
Rubin Jonathan (Reporting)
Supernus Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
Trump’s IRS Hands Massive ‘Victory Gift’ To 401K Owners (Ad)

The "Fake Media" has completely ignored Trump's genius "victory gift" to all America First patriots like you. A tax-free gift so powerful it could reshape the financial destinies of millions of IRA and 401(k) owners…

11/16/2023
4:00 PM
Mottola Frank (Reporting)
Supernus Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/16/2023
3:31 PM
NEWHALL CHARLES W III (Reporting)
Supernus Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/08/2023
3:14 PM
Supernus Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:SUPN) was last updated on 11/8/2024 by MarketBeat.com Staff
From Our Partners